James Hayden

Assistant Professor

  • 294 Citations
  • 7 h-Index
1991 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where James Hayden is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Sarcoma Medicine & Life Sciences
Extremities Medicine & Life Sciences
Epirubicin Medicine & Life Sciences
Ifosfamide Medicine & Life Sciences
Confidence Intervals Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Replacement Arthroplasties Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

  • 294 Citations
  • 7 h-Index
  • 15 Article
  • 1 Chapter

Identification of infectious species after resection of soft-tissue sarcomas

Ramsey, D. C., Jones, R. A., Weiss, J. K., Hayden, W., Hayden, J., Barnes, P. & Doung, Y-C., Jan 1 2019, In : Journal of surgical oncology.

Research output: Contribution to journalArticle

Sarcoma
Infection
Debridement
Anaerobic Bacteria
Proxy

Oncology Patients Are High Cost Outliers in Total Joint Replacement Bundled Payment Systems

Woelber, E., Gundle, K., Geddes, J., Schabel, K., Hayden, J., Hasan, S. R., Raymond, L. M. & Doung, Y-C., Jan 1 2019, (Accepted/In press) In : Journal of Arthroplasty.

Research output: Contribution to journalArticle

Replacement Arthroplasties
Costs and Cost Analysis
Osteoarthritis
Hospital Costs
Neoplasms
Open Access
Clinical Protocols
Sarcoma
Extremities
Randomized Controlled Trials
Ethics
1 Citation (Scopus)

Epirubicin and Ifosfamide with Preoperative Radiation for High-Risk Soft Tissue Sarcomas

Lu, E., Perlewitz, K. S., Hayden, J., Hung, A., Doung, Y-C., Davis, L., Mansoor, A., Vetto, J., Billingsley, K., Kaempf, A., Park, B. & Ryan, C., Apr 1 2018, In : Annals of Surgical Oncology. 25, 4, p. 920-927 8 p.

Research output: Contribution to journalArticle

Epirubicin
Ifosfamide
Sarcoma
Radiation
Extremities
5 Citations (Scopus)

Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma

Bharathy, N., Svalina, M. N., Settelmeyer, T. P., Cleary, M. M., Berlow, N. E., Airhart, S. D., Xiang, S., Keck, J., Hayden, J., Shern, J. F., Mansoor, A., Lathara, M., Srinivasa, G., Langenau, D. M. & Keller, C., 2017, In : Oncotarget. 8, 38, p. 62976-62983 8 p.

Research output: Contribution to journalArticle

Glycogen Synthase Kinase 3
Rhabdomyosarcoma
Alveolar Rhabdomyosarcoma
Skeletal Muscle
Embryonal Rhabdomyosarcoma